ANDA 74542, held by Chartwell Rx. Glipizide.
As of Nov 16, 2026, ANDA 74542 (Glipizide), held by Chartwell Rx, was first approved by FDA on Jun 20, 1995, with 1 approved supplement and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jun 20, 1995 | Original application | Approved |
| Mar 27, 2000 | Supplement 1Manufacturing | Approved | None posted |
| Jun 20, 1995 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters